Conexeu Sciences Independent Director Acquires 5.6% More Stock
Potential Conexeu Sciences Inc. (NASDAQ:CNXU) shareholders may wish to note that the Independent Director, Sebastian Purcell, recently bought US$500k worth of stock, paying US$3.00 for each share. While that's a very decent purchase to our minds, it was proportionally a bit modest, boosting their holding by just 5.6%.
Conexeu Sciences Insider Transactions Over The Last Year
In fact, the recent purchase by Sebastian Purcell was the biggest purchase of Conexeu Sciences shares made by an insider individual in the last twelve months, according to our records. So it's clear an insider wanted to buy, even at a higher price than the current share price (being US$2.99). It's very possible they regret the purchase, but it's more likely they are bullish about the company. To us, it's very important to consider the price insiders pay for shares. As a general rule, we feel more positive about a stock when an insider has bought shares at above current prices, because that suggests they viewed the stock as good value, even at a higher price. Sebastian Purcell was the only individual insider to buy during the last year.
Sebastian Purcell purchased 791.67k shares over the year. The average price per share was US$1.26. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!
Check out our latest analysis for Conexeu Sciences
There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of undervalued small cap companies that insiders are buying.
Insider Ownership
Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. We usually like to see fairly high levels of insider ownership. Conexeu Sciences insiders own about US$33m worth of shares. That equates to 39% of the company. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.
What Might The Insider Transactions At Conexeu Sciences Tell Us?
It's certainly positive to see the recent insider purchase. We also take confidence from the longer term picture of insider transactions. However, we note that the company didn't make a profit over the last twelve months, which makes us cautious. When combined with notable insider ownership, these factors suggest Conexeu Sciences insiders are well aligned, and that they may think the share price is too low. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Conexeu Sciences. At Simply Wall St, we've found that Conexeu Sciences has 3 warning signs (2 don't sit too well with us!) that deserve your attention before going any further with your analysis.
If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.